DrugPatentWatch Database Preview
Neopharma Company Profile
What is the competitive landscape for NEOPHARMA, and when can generic versions of NEOPHARMA drugs launch?
NEOPHARMA has twenty approved drugs.
There are five US patents protecting NEOPHARMA drugs.
There are ninety-three patent family members on NEOPHARMA drugs in forty-eight countries and twenty-four supplementary protection certificates in eight countries.
Summary for Neopharma
| International Patents: | 93 |
| US Patents: | 5 |
| Tradenames: | 16 |
| Ingredients: | 8 |
| NDAs: | 20 |
Drugs and US Patents for Neopharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neopharma | AUGMENTIN XR | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 050785-001 | Sep 25, 2002 | AB | RX | Yes | Yes | 7,250,176 | See Pricing | See Pricing | |||
| Neopharma | AMOXIL | amoxicillin | FOR SUSPENSION;ORAL | 062226-005 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Neopharma | IRBESARTAN | irbesartan | TABLET;ORAL | 203161-002 | Sep 27, 2012 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Neopharma | LAROTID | amoxicillin | FOR SUSPENSION;ORAL | 062226-004 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Neopharma | AUGMENTIN '250' | amoxicillin; clavulanate potassium | TABLET;ORAL | 050564-001 | Aug 6, 1984 | DISCN | Yes | No | See Pricing | See Pricing | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for NEOPHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Tablets | 1000 mg/62.5 mg | ➤ Subscribe | 2009-01-21 |
International Patents for Neopharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Peru | 00532001 | See Pricing |
| Germany | 10017883 | See Pricing |
| Austria | 242629 | See Pricing |
| European Patent Office | 1269997 | See Pricing |
| Hungary | 229097 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Neopharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0193256 | SPC/GB01/016 | United Kingdom | See Pricing | PRODUCT NAME: PIOGLITAZONE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE HYDROCHLORIDE SALT; REGISTERED: CH IKS 55 378 01 20000927; CH IKS 55 378 02 20000927; CH IKS 55 378 03 20000927; UK EU/1/00/151/001 20001011; UK EU/1/00/151/002 20001011; UK EU/1/00/151/003 20001011; UK EU/1/00/151/004 20001011; UK EU/1/00/151/005 20001011; UK EU/1/00/151/006 20001011 |
| 0454511 | 98C0028 | Belgium | See Pricing | PRODUCT NAME: IRBESARTAN; NATL. REGISTRATION NO/DATE: EU/1/97/046/001 19970827; FIRST REGISTRATION: CH 54250 02 19970815 |
| 0454511 | 24/1998 | Austria | See Pricing | PRODUCT NAME: ''IRBESARTAN'' UND DESSEN PHARMAZEUTISCH ANNEHMBAREN SALZE; NAT. REGISTRATION NO/DATE: EU/1/97/046/001 - EU/1/97/046/009 19970827; FIRST REGISTRATION: LI 5425002 19970815 |
| 0663828 | C300085 | Netherlands | See Pricing | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| 1746976 | LUC00026 | Luxembourg | See Pricing | PRODUCT NAME: IRINOTECAN SUCROSOFATE SALT, SUCH AS IRINOTECAN SUCROSOFATE SALT IN A PEGYLATED LIPOSOME, SUCH AS A LIPOSOME COMPRISING 1,2-DISTEAROYL-SN-PHOSPHATIDYLCHOLINE, CHOLESTEROL AND N-(OMEGA-METHOXY-POLY(ETHYLENE GLYCOL) (MOLECULAR WEIGHT 2000)-OXYCARBONYL)-1,2-DISTEAROYLPHOSPHATIDYL ETHANOLAMINE, E.G. IN THE MOLAR RATIO 3:2:0.015; AUTHORISATION NUMBER AND DATE: EU/1/16/1130 20161018 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
